Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors
Authors
Keywords
-
Journal
Nature Protocols
Volume 6, Issue 11, Pages 1775-1791
Publisher
Springer Nature America, Inc
Online
2011-10-28
DOI
10.1038/nprot.2011.387
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ras homologue enriched in brain is a critical target of farnesyltransferase inhibitors in non-small cell lung cancer cells
- (2010) Hang Zheng et al. CANCER LETTERS
- The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane
- (2010) N Berndt et al. CELL DEATH AND DIFFERENTIATION
- Evaluation of Alkyne-Modified Isoprenoids as Chemical Reporters of Protein Prenylation
- (2010) Amanda J. DeGraw et al. Chemical Biology & Drug Design
- A Tagging-via-substrate Approach to Detect the Farnesylated Proteome Using Two-dimensional Electrophoresis Coupled with Western Blotting
- (2010) Fredrick O. Onono et al. MOLECULAR & CELLULAR PROTEOMICS
- The Farnesyltransferase Inhibitor LB42708 Suppresses Vascular Endothelial Growth Factor-Induced Angiogenesis by Inhibiting Ras-dependent Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt Signal Pathways
- (2010) C.-K. Kim et al. MOLECULAR PHARMACOLOGY
- The chemical toolbox for monitoring protein fatty acylation and prenylation
- (2010) Rami N Hannoush et al. Nature Chemical Biology
- Targeting the protein prenyltransferases efficiently reduces tumor development in mice with K-RAS-induced lung cancer
- (2010) M. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older
- (2009) J.-L. Harousseau et al. BLOOD
- Phase II Trial of Tipifarnib plus Neoadjuvant Doxorubicin-Cyclophosphamide in Patients with Clinical Stage IIB-IIIC Breast Cancer
- (2009) J. A. Sparano et al. CLINICAL CANCER RESEARCH
- A novel approach to tag and identify geranylgeranylated proteins
- (2009) Lai N. Chan et al. ELECTROPHORESIS
- Blockade of Protein Geranylgeranylation Inhibits Cdk2-Dependent p27Kip1 Phosphorylation on Thr187 and Accumulates p27Kip1 in the Nucleus: Implications for Breast Cancer Therapy
- (2009) A. Kazi et al. MOLECULAR AND CELLULAR BIOLOGY
- Palmitoylation cycles and regulation of protein function (Review)
- (2009) Steinunn Baekkeskov et al. MOLECULAR MEMBRANE BIOLOGY
- Analysis of the eukaryotic prenylome by isoprenoid affinity tagging
- (2009) Uyen T T Nguyen et al. Nature Chemical Biology
- Phase I Study of Alternate-Week Administration of Tipifarnib in Patients with Myelodysplastic Syndrome
- (2008) R. Kurzrock et al. CLINICAL CANCER RESEARCH
- Tumorigenic activity and therapeutic inhibition of Rheb GTPase
- (2008) K. J. Mavrakis et al. GENES & DEVELOPMENT
- Ras oncogenes: split personalities
- (2008) Antoine E. Karnoub et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Caution! Analyze transcripts from conditional knockout alleles
- (2008) Shao H. Yang et al. TRANSGENIC RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started